Arthritis Clinical Trials in Omaha, NE

12 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Preventing Injured Knees From osteoArthritis: Severity Outcomes	Phase 2	Brigham and Women's Hospital	<1 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients	Phase 3	University of Pennsylvania	<1 mi
Innovations in Genicular Outcomes Registry	—	Pacira Pharmaceuticals, Inc	<1 mi
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response	Phase 3	University of Nebraska	<1 mi
Early Rheumatoid Arthritis Lung Disease Study	—	University of Nebraska	<1 mi
Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans	Phase 3	VA Office of Research and Development	<1 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain	Phase 2	Eli Lilly and Company	<1 mi
MOTION Clinical Trial	N/A	Moximed	<1 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	<1 mi
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.	Phase 1	AstraZeneca	<1 mi
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)	Phase 2	Merck Sharp & Dohme LLC	50 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.	Phase 3	Paradigm Biopharmaceuticals Ltd.	50 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.